Clinical trials
Withdrawn Phase 2 Anxiety Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| Aaron J. Janowsky | 1 |
| Allodynic Therapeutics, Inc | 1 |
| CB2 Insights | 1 |
| Canopy Growth Corporation | 1 |
| Jeff Taekman, M.D. | 1 |
| Mclean Hospital | 1 |
| Multidisciplinary Association for Psychedelic Studies | 1 |
| Nationwide Children's Hospital | 1 |
| State University of New York - Upstate Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxiety Disorders | 14 |
| Pain | 3 |
| Autism Spectrum Disorder | 2 |
| Child Development Disorders, Pervasive | 2 |
| Marijuana Abuse | 1 |
| Melanoma | 1 |
| Migraine Disorders | 1 |
| Neoplasms | 1 |
| Parasomnias | 1 |
| Phobia, Social | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.